Susceptibility to drug dependence and drug-induced psychoses is influenced not only by the pharmacological effects of the drug but also by the genetic factors of the individual. To clarify the latter, we investigated the association between methamphetamine (METH) dependence/psychosis and the hDAT1 gene (SLC6A3) encoding the dopamine transporter, which is the primary site of METH activity in the brain. Four exonic polymorphisms of the hDAT1 gene, 242C/T (exon 2), 1342A/G (exon 9), 2319G/A (3 0 UTR), and VNTR (3 0 UTR) were examined. Although there was no significant difference in genotypic and allelic distribution of the four polymorphisms between all METH dependence/psychosis patients (N ¼ 124) and controls (N ¼ 160), the patients with METH psychosis lasting for 1 month or more after discontinuance of METH consumption showed a significant excess of nine-or fewer repeat alleles of the VNTR in 3 0 UTR of the hDAT1 gene (P ¼ 0.0054, OR ¼ 4.24, 95% CI ¼ 2. 46-7.31). The present study demonstrated that the presence of nineor fewer repeat alleles of hDAT1 is a strong risk factor for a worse prognosis of METH psychosis.
INTRODUCTION
Genetic contributions to the etiology of substance abuse and dependence have been demonstrated by family, twin, and adoption studies. [1] [2] [3] [4] Kendler et al 2 showed that twin resemblance increases from occasional use to abuse or dependence in a population-based study of twins. The estimated heritability of cocaine use was 0.39, whereas the heritabilities of abuse and dependence were 0.79 and 0.65, respectively. 5 The heritability of abuse/dependence was relatively low for sedatives and opiates, but for psychostimulants such as amphetamines, it was as high as cocaine. 6 The primary site of biological activity of methamphetamine (METH) is the dopamine transporters in the brain. METH is taken into cytosol by dopamine transporters on the synaptic terminals of dopamine neurons, and endogenous dopamine is concurrently released through the transporters by carrier-exchange mechanisms, which results in a robust increase in the dopamine concentration in the synaptic clefts. The increase of dopamine release, especially in the accumbens, through dopamine transporters due to METH is primarily responsible for induction of its reinforcing and psychogenic effects. 7 Therefore, it is possible that variations in the dopamine transporter function produce the differences between individuals in vulnerability to METH dependence and/or psychosis. The hDAT1 gene (SLC6A3), which encodes the human dopamine transporter, was reported to be associated with other dependence behaviors such as alcohol dependence 8 and tobacco smoking. 9, 10 To examine the possible genetic influence of hDAT1 gene variants on the development of METH dependence/psychosis, four exonic polymorphisms, 242C/T (exon 2), 1342A/G (exon 9), 2319G/A (3 0 UTR of exon 15), and VNTR (3 0 UTR of exon 15), of the hDAT1 gene were analyzed in patients with METH dependence/psychosis in Japan.
The genotypic distribution and allelic frequency of three SNPs in exons 2, 9, and 15, and VNTR polymorphisms in the Table 1 . Distributions of the alleles of these four polymorphisms of the hDAT1 gene were within the values expected from Hardy-Weinberg equilibrium in both groups. The heterozygosity of these polymorphisms in the Japanese population seems to be different from that in Caucasians. [11] [12] [13] In particular, the frequency of a 10-repeat allele of the VNTR, a dominant allele, was 90.6% in the controls of the present study, and this value was similar to that of previous Japanese studies, 8, 14 but it was much higher than in Caucasian populations, which was around 70%. 12, 13 In contrast, the frequency of the 9-repeat allele in Japanese is lower than in Caucasians. These data indicate that distributions of hDAT1 gene polymorphisms differ among different ethnicities.
The genotypic and allelic distribution of the four polymorphisms in the hDAT1 gene examined did not differ significantly between controls and all patients with METH dependence/psychosis. The three SNPs did not differ significantly between any clinically defined subgroup of METH psychosis. The two SNPs in exons 2 and 9 are synonymous, and the other is located in the 3 0 UTR region. It is unlikely that these SNPs of the hDAT1 gene affect the function of the gene. There is possibility that the results were false negative because of insufficient statistical power to detect gene with small effects. The power analysis showed that the present sample size had a power of 0.81 to detect a significant allelic association between controls and patients, but it remarkably declined to 0.44 in comparison between subgroups of METH psychosis. Reanalyses should be needed after recruit of additional cases.
The allelic distribution of the VNTR polymorphism in 3 0 UTR was significantly different between subgroups of the transient and prolonged psychosis types (P ¼ 0.021). Patients with prolonged METH psychosis showed less frequency of multiple-substance abuse than those with transient type. It is unlikely that prolonged psychosis may result from abuse of other drugs except METH. Several lines of evidence indicate that VNTR in 3 0 UTR of the hDAT1 gene affects transcription and translation of the dopamine transporter. An in vivo study of human subjects using 123 I-beta-CIT and single photon emission computed tomography showed that individuals with the 9-repeat/10-repeat genotype had a 22% reduction of DAT protein in the putamen compared with 10-repeat homozygous individuals; 15 however, this result was not confirmed by a subsequent study. 16 In in vitro studies using luciferase assay and COS-7 cells, Fuke et al 17 showed that 7-and 9-repeat alleles have lower transcription activities compared to 10-and 11-repeat alleles; however, this was not confirmed by subsequent studies either. 18 Finally, Mill et al 19 measured mRNA levels of DAT in brains and lymphocytes directly and demonstrated clearly that 10-repeat/10-repeat, 9-repeat/10-repeat, and 9-repeat/9-repeat genotypes had linearly decreased expression of DAT mRNA in that order. These findings indicate that genotypes with 9-or fewer repeat alleles of the VNTR have lower transcription activity of the hDAT1 gene than those with 10-or more repeat alleles at least in Caucasian population. Although in vivo and in vitro data using human subjects or tissues of Japanese population are not available yet, it is possible that relationship between allelic variation and gene expression is similar in different ethnic populations. Therefore, alleles were divided into two groups, 9-or fewer and 10-or more repeat alleles (Table 2) . Using this dichotomy, the genotypic and allelic distribution of the hDAT1 gene significantly differed between transient-type METH psychosis and prolonged-type METH psychosis (genotype: G ¼ 5.66, P ¼ 0.017; allele: G ¼ 7.34, P ¼ 0.0054). Allelic distribution was still significant after Bonferroni's correction to avoid type I errors in multiple comparison. The odds ratio of an individual with a 9-or fewer repeat allele for prolonged type METH psychosis was 4.24 (95% CI ¼ 2.46-7.31).
The present study demonstrated that VNTR in 3 0 UTR of the hDAT1 gene was not associated with METH dependence, but it was significantly associated with worse prognosis for 20 who found that VNTR of the hDAT1 gene was not associated with cocaine dependence, but was associated with cocaine-induced paranoia, especially in Caucasian patients. The frequency of the 9-repeat allele was higher in patients with cocaine-induced paranoia than without it. Cocaine and METH belong to the psychostimulant agent category, and exert similar effects in the brain as indirect dopamine agonists, and their abuse can induce strong dependence and psychotic syndrome as well. A 9-or fewer repeat allele of VNTR of the hDAT1 gene, which may produce decreased transcription of the hDAT1 gene, could be a risk factor for development of psychostimulant-induced psychosis and its worse prognosis.
Several studies [21] [22] [23] revealed by positron emission tomography that dopamine transporters in the caudate/putamen of METH abusers were significantly decreased. Some patients showed a reduction of dopamine transporters lasting for several months 21 or several years 22 after detoxification. Sekine et al 22 showed a reduction of dopamine transporters not only in the caudate/putamen, but also in nucleus accumbens and prefrontal cortex of METH abusers. In addition, the rate of the reduction of dopamine transporters was significantly correlated with the duration of METH consumption and the severity of METH psychosis. These findings may suggest that every METH consumption reduces dopamine transporters one step, which may persist, accumulate, and result in a substantial reduction of dopamine transporters and, finally, development of severe psychotic symptoms. Such a lasting decrease in dopamine transporter density of METH abusers may result from potential METHinduced dopamine neurotoxicity. It is well documented in experimental animals that METH produces nerve terminal degeneration of dopamine and serotonin by multiple mechanisms. 24 As one of major mechanisms, an increased dopamine release by METH and subsequent auto-oxidation of dopamine to highly reactive free radicals should be involved. Elevated dopamine concentration in synaptic clefts is removed rapidly by reuptake through dopamine transporters. Decreased dopamine transporter density may delay dopamine clearance and enhance neurotoxicity. Based on the present findings, it is postulated that individuals with a genetically reduced density of dopamine transporters because of the presence of a 9-or fewer repeat allele of the hDAT1 gene are more susceptible to neurotoxicity of METH and prolonged METH psychosis if they abuse METH.
SUBJECTS AND METHODS
The subjects were 124 unrelated patients with METH dependence and psychotic disorder (94 males and 21 females, aged 35.8711.3 years) meeting the ICD-10-DCR criteria (F15.2 and F15.5) who were outpatients or inpatients of psychiatric hospitals of the Japanese Genetics Initiative for Drug Abuse (JGIDA), and 160 age-, gender-, and geographical origin-matched normal controls (125 males and 35 females, aged 36.0710.2 years). The control group consisted mostly of medical staff members who had no past individual or family history of drug dependence or psychotic disorders. Diagnoses were made by two trained psychiatrists by interview and all available information, including hospital records. Patients were excluded if they had a clinical diagnosis of schizophrenia, any other psychotic disorder, or an organic mental syndrome. All subjects were Japanese, born and living in selected areas of Japan including northern Kyushu, Setouchi, Chube, Tokai, and Kanto. This study was performed after obtaining approval from the ethics committees of each institute of JGIDA, and all subjects provided written informed consent for the use of their DNA samples in this research.
The patients were divided into subgroups by several characteristic clinical features. The patients were divided by multiple-substance abuse status; 36 patients had abused only METH in their lifetime, and 89 patients had abused drugs other than METH in the past or present. After METH, organic solvents were the most frequently abused drugs, followed by marijuana. Cocaine and heroine abuse were rarely seen in the present study. The course of METH psychosis varied among patients, and some patients showed continuous psychotic symptoms even after METH discontinuance, as previously reported. 25, 26 Therefore, patients were divided into two categories of psychosis, the transient type and the prolonged type, based on the duration of the psychotic state after METH discontinuance. Patients with the transient type showed improvement of psychotic symptoms within 1 month after the discontinuance of METH consumption and beginning of treatment with neuroleptics, and those with the prolonged type had psychosis that continued for more than 1 month even after the discontinuance of METH consumption and beginning of neuroleptic treatment. In this study, 66 patients had the transient type and 47 had the prolonged type of METH psychosis. The subgroup of prolonged type of METH psychosis may include some patients suffering from protracted endogenous psychosis like schizophrenia with coincidental onset with transient METH psychosis. It seems difficult to exclude completely such comorbid cases from the present study. However, patients with predominant negative or disorganized symptoms, which are observed rarely in METH psychosis patients, were excluded to keep homogeneity of subgroup.
It has been well documented that once METH psychosis has developed, patients in the remission state become liable to spontaneous relapse without reconsumption of METH. 25, 26 It is postulated that a sensitization phenomenon induced by repeated consumption of METH develops in the brains of METH psychosis patients and is the neural basis for enhanced susceptibility to relapse. 7 Therefore, the patients were divided into two groups according to the presence or absence of spontaneous relapse. The patients with a history of spontaneous relapse were 41 and those without were 71.
Genomic DNA was extracted from peripheral leukocytes by the standard phenol/CHCl 3 method. The region containing the three SNPs was amplified by PCR using a unique primer sets 11, 27 and genotyping was determined as RFLP using restriction enzymes as follows: 242C4T (exon 2), 5 0 -AAGAGGGAAGAAGCACAGAA-3 0 , 5 0 -GGAGCTGGTGAGCT-GCGGTCC-3 0 , and CpoI; 1342A4G (exon 9), 5 0 -CACAGC-GTGGGCTCTGTG-3 0 , 5 0 -GGTGGAAGGAACCCAACTG-3 0 , and DdeI; 2319G4A (exon 15); 5 0 -CCGTGTCTTGTGTT-GCTGTA-3 0 , 5 0 -ACGGGGATTCTCAGGAGGTG-3 0 , and MspI. PCR was performed in a final volume of 15 ml with 10% dimethyl sulfoxide and 1 U of Supertaq (Sawady Co., Japan) in the reaction mixture. The amplification conditions were initiated at 951C for 5 min, followed by 35 cycles consisting of denaturation at 951C for 1 min, annealing at the appropriate primer-pair annealing temperature for 30 s and extension at 721C for 1 min, with a final extension step of 10 min at 721C. After digestion, PCR products were analyzed on 2-4.5% agarose gels. VNTR polymorphism in exon 15 was amplified with 5 0 -TGTGGTGTAGGGAACGGCCTGAG-3 0 , 5 0 -CTTCCTGGAGGTCACGGCTCAAGG-3 0 . The forward primer was 5 0 -end-labeled with Texas red, and PCR products and the Texas red-labeled size standard were electrophoretically run on 6% polyacrylamide gels using an SQ5500 DNA sequencer (Hitachi Co., Japan). Each length was calculated using Fragyls 2 (Hitachi Co., Japan) computer software. All genotyping was carried out in a blinded fashion with control and patient samples randomly mixed. The presence of the Hardy-Weinberg equilibrium was tested using a w 2 goodness-of-fit test. Statistical analysis of SNPs was performed using the log-likelihood ratio test or Fisher's exact test at a significance level of 0.05, two-tailed, and that for VNTR polymorphism was conducted using the MonteCarlo method as implemented in CLUMP. 28 
